Literature DB >> 15735736

HPV16 E5 protein disrupts the c-Cbl-EGFR interaction and EGFR ubiquitination in human foreskin keratinocytes.

Benyue Zhang1, Anjaiah Srirangam, David A Potter, Ann Roman.   

Abstract

The E5 protein of human papillomavirus type 16 (HPV16) is a small hydrophobic protein, which localizes to the cell membrane, Golgi apparatus and endosomes. HPV16 E5 enhances the activation of the epidermal growth factor (EGFR). The activated EGFR is downregulated through the endocytic pathway, where E5 has been shown to inhibit endosomal acidification and trafficking. Ubiquitination of the activated EGFR plays a role in this downregulation. c-Cbl is a ubiquitin ligase that associates with the activated EGFR and targets it for degradation. Since E5 has been shown to form a complex with the EGFR, we tested the hypothesis that E5 affects the interaction of c-Cbl with the EGFR. We found a significant decrease of c-Cbl bound to the EGFR and of ubiquitinated EGFR in the presence of E5. E5 did not affect c-Cbl steady-state level, phosphorylation or translocation to the membrane. This novel result suggests that HPV16 E5 may, at least in part, upregulate EGFR-mediated signal transduction by inhibiting the interaction of c-Cbl with the EGFR, thereby decreasing c-Cbl-mediated degradation of the EGFR.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15735736      PMCID: PMC2730517          DOI: 10.1038/sj.onc.1208453

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  46 in total

Review 1.  The role of the E6-p53 interaction in the molecular pathogenesis of HPV.

Authors:  M Thomas; D Pim; L Banks
Journal:  Oncogene       Date:  1999-12-13       Impact factor: 9.867

2.  Degradation of the retinoblastoma tumor suppressor by the human papillomavirus type 16 E7 oncoprotein is important for functional inactivation and is separable from proteasomal degradation of E7.

Authors:  S L Gonzalez; M Stremlau; X He; J R Basile; K Münger
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

3.  Human papilloma virus (HPV)-E6/E7 and epidermal growth factor receptor (EGF-R) protein levels in cervical cancer and cervical intraepithelial neoplasia (CIN).

Authors:  S P Mathur; R S Mathur; P F Rust; R C Young
Journal:  Am J Reprod Immunol       Date:  2001-10       Impact factor: 3.886

4.  Regulation of epidermal growth factor receptor signaling by endocytosis and intracellular trafficking.

Authors:  P Burke; K Schooler; H S Wiley
Journal:  Mol Biol Cell       Date:  2001-06       Impact factor: 4.138

5.  Ligand-induced ubiquitination of the epidermal growth factor receptor involves the interaction of the c-Cbl RING finger and UbcH7.

Authors:  M Yokouchi; T Kondo; A Houghton; M Bartkiewicz; W C Horne; H Zhang; A Yoshimura; R Baron
Journal:  J Biol Chem       Date:  1999-10-29       Impact factor: 5.157

Review 6.  The interaction between p53 and papillomaviruses.

Authors:  F Mantovani; L Banks
Journal:  Semin Cancer Biol       Date:  1999-12       Impact factor: 15.707

Review 7.  Immortalization of human cells and their malignant conversion by high risk human papillomavirus genotypes.

Authors:  H zur Hausen
Journal:  Semin Cancer Biol       Date:  1999-12       Impact factor: 15.707

8.  Multiple autophosphorylation site mutations of the epidermal growth factor receptor. Analysis of kinase activity and endocytosis.

Authors:  A Sorkin; C Waters; K A Overholser; G Carpenter
Journal:  J Biol Chem       Date:  1991-05-05       Impact factor: 5.157

Review 9.  Cbl: many adaptations to regulate protein tyrosine kinases.

Authors:  C B Thien; W Y Langdon
Journal:  Nat Rev Mol Cell Biol       Date:  2001-04       Impact factor: 94.444

10.  c-Cbl ubiquitinates the EGF receptor at the plasma membrane and remains receptor associated throughout the endocytic route.

Authors:  A A de Melker; G van der Horst; J Calafat; H Jansen; J Borst
Journal:  J Cell Sci       Date:  2001-06       Impact factor: 5.285

View more
  38 in total

Review 1.  Cellular transformation by human papillomaviruses: lessons learned by comparing high- and low-risk viruses.

Authors:  Aloysius J Klingelhutz; Ann Roman
Journal:  Virology       Date:  2012-01-27       Impact factor: 3.616

2.  Human papillomavirus 16 E5 induces bi-nucleated cell formation by cell-cell fusion.

Authors:  Lulin Hu; Kendra Plafker; Valeriya Vorozhko; Rosemary E Zuna; Marie H Hanigan; Gary J Gorbsky; Scott M Plafker; Peter C Angeletti; Brian P Ceresa
Journal:  Virology       Date:  2008-11-28       Impact factor: 3.616

3.  E5 can be expressed in anal cancer and leads to epidermal growth factor receptor-induced invasion in a human papillomavirus 16-transformed anal epithelial cell line.

Authors:  Erin Isaacson Wechsler; Sharof Tugizov; Rossana Herrera; Maria Da Costa; Joel M Palefsky
Journal:  J Gen Virol       Date:  2018-04-06       Impact factor: 3.891

Review 4.  Role of Zn2+ ions in host-virus interactions.

Authors:  Maciej Lazarczyk; Michel Favre
Journal:  J Virol       Date:  2008-09-10       Impact factor: 5.103

5.  The canine papillomavirus e5 protein signals from the endoplasmic reticulum.

Authors:  Rachel Condjella; Xuefeng Liu; Frank Suprynowicz; Hang Yuan; Sawali Sudarshan; Yuhai Dai; Richard Schlegel
Journal:  J Virol       Date:  2009-10-07       Impact factor: 5.103

Review 6.  Human papillomavirus-16 E5 protein: oncogenic role and therapeutic value.

Authors:  Niladri Ganguly
Journal:  Cell Oncol (Dordr)       Date:  2012-01-20       Impact factor: 6.730

7.  Itraconazole suppresses the growth of glioblastoma through induction of autophagy: involvement of abnormal cholesterol trafficking.

Authors:  Rui Liu; Jingyi Li; Tao Zhang; Linzhi Zou; Yi Chen; Kui Wang; Yunlong Lei; Kefei Yuan; Yi Li; Jiang Lan; Lin Cheng; Na Xie; Rong Xiang; Edouard C Nice; Canhua Huang; Yuquan Wei
Journal:  Autophagy       Date:  2014-05-15       Impact factor: 16.016

Review 8.  Human papillomavirus type 16 E5 protein as a therapeutic target.

Authors:  Sang-Woo Kim; Joo-Sung Yang
Journal:  Yonsei Med J       Date:  2006-02-28       Impact factor: 2.759

9.  Molecular characterization of EGFR, PDGFRA and VEGFR2 in cervical adenosquamous carcinoma.

Authors:  Adhemar Longatto-Filho; Céline Pinheiro; Olga Martinho; Marise A R Moreira; Luiz F J Ribeiro; Geraldo S Queiroz; Fernando C Schmitt; Fátima Baltazar; Rui M Reis
Journal:  BMC Cancer       Date:  2009-06-29       Impact factor: 4.430

10.  HPV infection and EGFR activation/alteration in HIV-infected East African patients with conjunctival carcinoma.

Authors:  Jing Jie Yu; Pingfu Fu; John J Pink; Dawn Dawson; Jay Wasman; Jackson Orem; Walter O Mwanda; Honglan Zhu; Xiaobing Liang; Yi Guo; William P Petros; Ronald T Mitsuyasu; Henry Wabinga; Scot C Remick
Journal:  PLoS One       Date:  2010-05-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.